Charles Y. Lin - Feb 21, 2024 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
SR VP, RESEARCH & DEVELOPMENT
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Stock symbol
KRON
Transactions as of
Feb 21, 2024
Transactions value $
-$12,685
Form type
4
Date filed
2/23/2024, 08:07 PM
Previous filing
Feb 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRON Common Stock Sale -$12.7K -12K -4.88% $1.05 235K Feb 21, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.
F2 The weighted average sale price for the transaction reported was $1.0539, and the range of prices were between $1.02 to $1.11. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.